Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Celularity Inc (CELU)
Celularity Inc (CELU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 83,694
  • Shares Outstanding, K 193,782
  • Annual Sales, $ 17,980 K
  • Annual Income, $ 14,190 K
  • 60-Month Beta 0.25
  • Price/Sales 5.22
  • Price/Cash Flow 2.37
  • Price/Book 2.78
Trade CELU with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.06
  • Most Recent Earnings $-0.06 on 01/02/24
  • Latest Earnings Date 04/02/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 335.17% ( -17.68%)
  • Historical Volatility 182.21%
  • IV Percentile 38%
  • IV Rank 22.00%
  • IV High 1,289.74% on 08/17/23
  • IV Low 65.86% on 04/17/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 5
  • Volume Avg (30-Day) 25
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1,399
  • Open Int (30-Day) 1,418

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2610 +65.48%
on 01/22/24
0.5655 -23.63%
on 02/01/24
+0.1379 (+46.90%)
since 01/19/24
3-Month
0.1590 +171.64%
on 12/27/23
0.5655 -23.63%
on 02/01/24
+0.2272 (+110.99%)
since 11/21/23
52-Week
0.1590 +171.64%
on 12/27/23
0.8900 -51.47%
on 06/14/23
-0.2064 (-32.34%)
since 02/21/23

Most Recent Stories

More News
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Celularity Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

CELU : 0.4319 (-8.11%)
HOOKIPA Pharma Inc. (HOOK) Reports Q1 Loss, Lags Revenue Estimates

HOOKIPA Pharma Inc. (HOOK) delivered earnings and revenue surprises of -12.50% and 15.31%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

HOOK : 0.6577 (-1.10%)
CELU : 0.4319 (-8.11%)
Akoya Biosciences (AKYA) Reports Q1 Loss, Tops Revenue Estimates

Akoya (AKYA) delivered earnings and revenue surprises of -6.52% and 5.11%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

AKYA : 5.27 (-6.39%)
CELU : 0.4319 (-8.11%)
Arvinas, Inc. (ARVN) Reports Q1 Loss, Misses Revenue Estimates

Arvinas, Inc. (ARVN) delivered earnings and revenue surprises of -5.48% and 5.88%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ARVN : 47.70 (-5.73%)
CELU : 0.4319 (-8.11%)
Biogen (BIIB) Beats on Q1 Earnings, Ends Some Research Programs

Biogen (BIIB) beats first-quarter estimates for earnings and sales. It maintains its 2023 guidance. Stock drops in pre-market trading.

BIIB : 221.11 (+0.87%)
RHHBY : 32.9100 (+0.52%)
ANVS : 10.18 (+1.19%)
CELU : 0.4319 (-8.11%)
Assertio (ASRT) to Report Q1 Earnings: What's in the Cards?

On Assertio Therapeutics' (ASRT) Q1 earnings call, investors will likely focus on the sales performance of its rheumatology, pain and inflammation medicines.

RETA : 172.36 (+0.02%)
ASRT : 0.7892 (-4.12%)
AQST : 2.51 (-5.28%)
CELU : 0.4319 (-8.11%)
Best Momentum Stocks to Buy for April 12th

CELU, PPG and LSCC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on April 12, 2023.

PPG : 142.65 (+1.06%)
LSCC : 72.21 (+0.06%)
CELU : 0.4319 (-8.11%)
New Strong Buy Stocks for April 12th

CELU, MGI, LRMR, EQRX and SRZN have been added to the Zacks Rank #1 (Strong Buy) List on April 12, 2023.

MGI : 10.99 (unch)
LRMR : 12.03 (-0.25%)
CELU : 0.4319 (-8.11%)
SRZN : 13.70 (-1.79%)
EQRX : 2.34 (-2.09%)
Immuneering Corporation (IMRX) Surges 18.5%: Is This an Indication of Further Gains?

Immuneering Corporation (IMRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength...

IMRX : 6.58 (-2.66%)
CELU : 0.4319 (-8.11%)
Celularity Announces Agreement with AD Ports Group for Exclusive Product Distribution in Various Territories in the GCC and Egypt

/PRNewswire/ -- Celularity Inc. (Nasdaq: CELU) ("Celularity"), a biotechnology company developing placental-derived allogenic cell therapies and biomaterial...

CELU : 0.4319 (-8.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Celularity Inc. is a clinical stage biotechnology company. It involved in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified NK cells, genetically-modified NK cells, T cells engineered with a CAR and mesenchymal-like adherent stromal cells...

See More

Key Turning Points

3rd Resistance Point 0.5205
2nd Resistance Point 0.5002
1st Resistance Point 0.4661
Last Price 0.4319
1st Support Level 0.4117
2nd Support Level 0.3914
3rd Support Level 0.3573

See More

52-Week High 0.8900
Fibonacci 61.8% 0.6108
Fibonacci 50% 0.5245
Fibonacci 38.2% 0.4382
Last Price 0.4319
52-Week Low 0.1590

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar